Free Trial

Salesforce (CRM) Stock Forecast & Price Target

Salesforce logo
$240.63 -8.54 (-3.43%)
Closing price 03:59 PM Eastern
Extended Trading
$240.90 +0.27 (+0.11%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
3
Hold
8
Buy
31

Based on 42 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 42 analysts, 3 have given a sell rating, 8 have given a hold rating, 27 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$348.16
44.69% Upside
According to the 42 analysts' twelve-month price targets for Salesforce, the average price target is $348.16. The highest price target for CRM is $440.00, while the lowest price target for CRM is $200.00. The average price target represents a forecasted upside of 44.69% from the current price of $240.63.
Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

Sign Up

CRM Analyst Ratings Over Time

TypeCurrent Forecast
8/7/24 to 8/7/25
1 Month Ago
7/8/24 to 7/8/25
3 Months Ago
5/9/24 to 5/9/25
1 Year Ago
8/8/23 to 8/7/24
Strong Buy
4 Strong Buy rating(s)
4 Strong Buy rating(s)
5 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
27 Buy rating(s)
28 Buy rating(s)
32 Buy rating(s)
24 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
5 Hold rating(s)
9 Hold rating(s)
Sell
3 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$348.16$349.08$350.56$292.79
Forecasted Upside44.69% Upside27.51% Upside27.30% Upside21.98% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Salesforce Stock vs. The Competition

TypeSalesforceComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.76
2.66
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside39.90% Upside70.11% Upside13.97% Upside
News Sentiment Rating
Positive News

See Recent CRM News
Positive News
Positive News

Subscribe to MarketBeat All Access for the recommendation accuracy rating
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/14/2025Royal Bank Of Canada
3 of 5 stars
R. Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$275.00+5.68%
7/11/2025JMP Securities
3 of 5 stars
Patrick Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$430.00+62.91%
7/10/2025Cantor Fitzgerald
4 of 5 stars
M. Vanvliet
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Cautious
7/10/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Bachman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$350.00 ➝ $335.00+25.53%
6/18/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetOverweight ➝ Overweight$404.00+56.00%
6/10/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$370.00+36.04%
6/5/2025Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
H. Engel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/30/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$320.00 ➝ $295.00+11.92%
5/30/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$311.00 ➝ $309.00+16.88%
5/29/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$393.00 ➝ $404.00+46.87%
5/29/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Turrin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$255.00 ➝ $275.00+4.94%
5/29/2025Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Nehal Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$423.00 ➝ $396.00+51.50%
5/29/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raimo Lenschow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$425.00 ➝ $347.00+34.38%
5/29/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kash Rangan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$340.00 ➝ $385.00+47.64%
5/29/2025Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Moerdler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetUnderperform ➝ Underperform$243.00 ➝ $255.00-7.30%
5/28/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$315.00 ➝ $335.00+21.53%
5/28/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform$200.00-27.15%
5/28/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$400.00 ➝ $350.00+26.39%
5/28/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Scott Berg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$400.00+44.44%
5/28/2025Westpark Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Shauger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00+15.55%
5/15/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gregg Moskowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$425.00 ➝ $380.00+30.85%
4/21/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
3/31/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Thill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$425.00 ➝ $375.00+43.23%
3/20/2025Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Beynon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$320.00 ➝ $320.00+14.67%
3/17/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetSector Outperform ➝ Sector Outperform$400.00 ➝ $345.00+23.43%
2/27/2025Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Yun Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$330.00 ➝ $300.00+0.80%
2/27/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Parker Lane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$425.00 ➝ $375.00+24.79%
2/27/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rob Oliver
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$430.00 ➝ $400.00+30.21%
2/27/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$440.00 ➝ $400.00+30.21%
2/19/2025Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
O. Sheikh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
1/17/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Derrick Wood
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$380.00 ➝ $400.00+24.62%
12/18/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$425.00 ➝ $425.00+21.08%
12/13/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$440.00+22.84%
12/4/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$340.00 ➝ $380.00+3.28%
12/4/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$380.00 ➝ $400.00+20.57%
10/17/2024CfraAaron Siegel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$343.00+16.88%
10/2/2024Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/30/2024Phillip Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Accumulate$305.00+20.72%
8/29/2024FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seyrafi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.

Discover the under-the-radar project I believe will skyrocket as a result.
8/29/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$335.00 ➝ $335.00+28.58%
8/29/2024Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$325.00 ➝ $350.00+35.19%
8/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+13.39%
5/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$350.00 ➝ $300.00+39.82%
4/16/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$365.00+33.82%
3/6/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$290.00 ➝ $354.00+16.46%
9/15/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$267.00+22.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:30 PM ET.


Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 4, 2025. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

  • The company recently reported earnings per share (EPS) of $2.58, exceeding analyst expectations, which indicates strong financial performance and effective management.
  • Salesforce, Inc. has shown a year-over-year revenue growth of 7.6%, suggesting a positive trend in sales and customer acquisition.
  • The current stock price is around $265, which may present a buying opportunity for investors looking for growth potential in the tech sector.
  • With a dividend payout ratio of 25.98%, Salesforce, Inc. demonstrates a commitment to returning value to shareholders while still reinvesting in growth.
  • Analysts have a consensus rating of "Moderate Buy" with an average target price of $348.16, indicating potential upside for investors.

Salesforce
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

  • Despite recent growth, the stock has faced downgrades from some analysts, which may indicate concerns about future performance.
  • Salesforce, Inc. has a relatively low dividend yield of 0.7%, which may not be attractive for income-focused investors.
  • Insider selling has been observed, with the CEO recently selling shares, which could raise concerns about confidence in the company's future.
  • Some analysts have issued "sell" ratings, reflecting skepticism about the stock's short-term performance amidst market volatility.
  • The competitive landscape in the CRM sector is intense, with many players vying for market share, which could impact Salesforce's growth prospects.

CRM Forecast - Frequently Asked Questions

According to the research reports of 42 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $348.16, with a high forecast of $440.00 and a low forecast of $200.00.

42 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 3 sell ratings, 8 hold ratings, 27 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 44.69% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 3 downgrades and 1 upgrade by analysts.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.76 while the average consensus rating score for "computer and technology" companies is 2.66. Learn more on how CRM compares to other companies.


This page (NYSE:CRM) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners